All lobbying filings

Bockorny Group, Inc.

Bockorny Group, Inc. filed a Q4 report for Agragene on January 20, 2026, reporting $6,000 in lobbying income.

Lobbying for Agragene · Biotechnology

As filed: BOCKORNY GROUP, INC. for AGRAGENE.

All filings by Bockorny Group, Inc. · Everything Agragene has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$6,000

What the client paid this registrant for the period.

Client based in

Missouri

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Issues relating to regulation of gene-edited insects. Issues relating to New World screwworm-no specific legislation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem